The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)

Chakrani, Z., Patel, M., Mellgard, G., McCroskery, S., Saffran, N., Taylor, N., Liaw, B. C., Galsky, M., Oh, W., Tsao, C.-K., Ganta, T., & Patel, V. (2024). The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Clinical Genitourinary Cancer, 22(6), 102227. https://doi.org/10.1016/j.clgc.2024.102227
Authors:
Zakaria Chakrani
Mann Patel
George Mellgard
Stephen McCroskery
Nathaniel Saffran
Nicole Taylor
Bobby C Liaw
Matthew Galsky
William Oh
Che-Kai Tsao
Teja Ganta
Vaibhav Patel
Affiliated Authors:
George Mellgard
Columbia Affiliation:
Subjects:
Prostatic Neoplasms, Castration-Resistant (MeSH)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
Author Keywords:
mcrpc
overall survival
progression-free survival
prostate cancer
statin
elink
Publication Type:
Article
Unique ID:
10.1016/j.clgc.2024.102227
PMID:
39437664
DOI:
10.1016/j.clgc.2024.102227
Journal:
Clinical Genitourinary Cancer
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: